New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
14:02 EDTPCRXPacira Pharmaceuticals reports positive results from studies of EXPAREL
Pacira Pharmaceuticals announced new data evaluating the use of EXPAREL to manage postsurgical pain following total joint arthroplasty, which included hip and knee replacement surgery. The data, derived from two studies presented at the 81st annual meeting of the American Academy of Orthopedic Surgeons, demonstrated the benefits of EXPAREL in improving a variety of key post-TJA outcomes including pain management, incidence of accidental falls, opioid consumption and hospital stay/costs. The AAOS 2014 meeting is being held in New Orleans from March 11-15.
News For PCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 5, 2015
07:54 EDTPCRXFDA PDUFA Date for Pacira's Exparel is March 5, 2015
March 4, 2015
08:44 EDTPCRXPacira shares oversold after CRL pullback, says Brean Capital
Brean Capital believes Pacira shares are oversold following the pullback after the company received a Complete Response Letter from the FDA for its nerve block drug, Exparel. The firm feels even if there was a delay in the drug by two years the company can still support a higher valuation. Brean Capital reiterated its Buy rating but lowered its price target to $121 from $135 on Pacira shares.
March 3, 2015
08:09 EDTPCRXPacira price target lowered to $128 from $163 at Canaccord
Subscribe for More Information
March 2, 2015
09:22 EDTPCRXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Amira Nature Foods (ANFI), up 8.6%... Stratasys (SSYS), up 3.6%... Magnum Hunter (MHR), up 3%. ALSO HIGHER: Mavenir Systems (MVNR), up 19.1% after Mitel (MITL) agrees to acquire Mavenir Systems for $560M... Athersys (ATHX), up 19.7% following license agreement and collaboration with Chugai... OHR Pharmaceutical (OHRP), up 11.4% following additional positive data from OHR-102 IMPACT study... NXP Semiconductors (NXPI), up 14% following merger agreement with Freescale Semiconductor (FSL). Freescale Semiconductor is up 9.1%... Mast Therapeutics (MSTX), up 7.7% following positive results from Vepoloxamer study. DOWN AFTER EARNINGS: JinkoSolar (JKS), down 4.7%... Scorpio Tankers (STNG), down 4.5%. ALSO LOWER: Lumber Liquidators (LL), down 24.2% following CBS' 60 Minutes says that the company is linked to health and safety violations... Aruba Networks (ARUN), down 1.7% after HP (HPQ) confirms deal to acquire Aruba Networks for $24.67... Pacira Pharmaceuticals (PCRX), down 14.4% after receiving complete response letter from FDA for sNDA in use of Exparel... (WBAI), down 14.4% after announcing that temporary suspension will adversely impact financial results.
06:33 EDTPCRXPacira receives complete response letter from FDA for sNDA in use of Exparel
Subscribe for More Information
February 26, 2015
10:00 EDTPCRXOn The Fly: Analyst Downgrade SummaryStarz
Subscribe for More Information
07:43 EDTPCRXPacira downgraded at BofA/Merrill
Subscribe for More Information
06:17 EDTPCRXPacira downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
February 25, 2015
07:26 EDTPCRXPacira price target raised to $135 from $111 at Brean Capital
Subscribe for More Information
February 24, 2015
06:43 EDTPCRXPacira sees FY15 Exparel revenue $310M-$330M
Subscribe for More Information
06:42 EDTPCRXPacira reports Q4 non-GAAP EPS 35c, consensus 28c
Reports Q4 revenue $61.8M, consensus $62.12M

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use